Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
Kathleen A. Estes
Advertisement
Kathleen A. Estes, PhD, is director of research communications atBioPlan Associates, Inc. She is an experienced market research and data trends analyst, author, and editor, kestes@bioplanassociates.com.
Articles by Kathleen A. Estes
Advertisement
Latest Updated Articles
Update on Continuous Bioprocessing: From the Industry’s Perception to RealityPublished: June 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Establishing Risk Assessments for AI in Bio-Manufacturing
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
